What is the maximum recommended dose of Losartan (angiotensin II receptor antagonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Losartan

The maximum recommended dose of losartan is 100 mg once daily for hypertension, hypertensive patients with left ventricular hypertrophy, and nephropathy in type 2 diabetic patients. 1

Dosing Guidelines for Different Indications

Hypertension

  • The usual starting dose for adult hypertension is 50 mg once daily 1
  • The dosage can be increased to a maximum of 100 mg once daily as needed to control blood pressure 1
  • A lower starting dose of 25 mg is recommended for patients with possible intravascular depletion (e.g., those on diuretic therapy) 1
  • According to the 2017 ACC/AHA guidelines, losartan's usual dose range is 50-100 mg per day, which can be administered in 1-2 daily frequencies 2

Hypertensive Patients with Left Ventricular Hypertrophy

  • The usual starting dose is 50 mg of losartan once daily 1
  • The dose can be increased to 100 mg once daily based on blood pressure response 1
  • Hydrochlorothiazide may be added to the regimen as needed 1

Nephropathy in Type 2 Diabetic Patients

  • The usual starting dose is 50 mg once daily 1
  • The dose should be increased to 100 mg once daily based on blood pressure response 1
  • Clinical evidence supports that 100 mg of losartan significantly reduced the albumin-to-creatinine ratio (ACR) and the risks of chronic kidney disease stage 5 and doubling of serum creatinine level compared with placebo 2

Special Populations and Considerations

Hepatic Impairment

  • In patients with mild-to-moderate hepatic impairment, the recommended starting dose is 25 mg once daily 1
  • Losartan has not been studied in patients with severe hepatic impairment 1

Renal Impairment

  • No dosage adjustment is necessary for patients with various degrees of renal insufficiency 3
  • Losartan is not removed during hemodialysis 3
  • Losartan regimens (50-100 mg) were well tolerated in patients with chronic renal disease, including those on hemodialysis 4

Optimal Dosing for Specific Conditions

Diabetic Nephropathy

  • For type 1 diabetic patients with diabetic nephropathy, studies suggest that 100 mg daily is the optimal dose for renoprotection and blood pressure reduction 5
  • Losartan 100 mg daily was significantly more effective than 50 mg daily in reducing albuminuria (48% vs 30% reduction) 5
  • Increasing the dose to 150 mg daily did not provide additional benefit over the 100 mg dose 5

Non-Diabetic Proteinuria

  • For non-diabetic patients with nephrotic range proteinuria, 100 mg of losartan appears to be the optimal antiproteinuric dose 6
  • The 50 mg dose was less effective, and the 150 mg dose did not provide additional antiproteinuric benefit 6

Clinical Pharmacology

  • Losartan is rapidly absorbed after oral administration, reaching maximum concentrations in 1-2 hours 3
  • Approximately 14% of a losartan dose is converted to the pharmacologically active E3174 metabolite, which is 10-40 times more potent than the parent compound 3
  • The pharmacokinetics of losartan are linear and dose-proportional 3

Safety Considerations

  • Losartan should be avoided during pregnancy, particularly in the second and third trimesters 3
  • Do not use in combination with ACE inhibitors or direct renin inhibitors due to increased risk of hyperkalemia and renal dysfunction 7
  • Monitor renal function and potassium levels, especially in patients with renal impairment 7

In conclusion, while losartan doses up to 150 mg have been studied in certain populations, the FDA-approved maximum dose and the dose supported by major clinical guidelines is 100 mg once daily for hypertension, left ventricular hypertrophy, and diabetic nephropathy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Research

Optimal dose of losartan for renoprotection in diabetic nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002

Research

Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Guideline

Optimal Dosing of Losartan for Hypertension and Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.